1. Forman HP, Middleton WD, Melson GL, McClennan BL. Hyperechoic renal cell carcinomas: increase in detection at US. Radiology. 1993; 188:431–434.
2. Heidenreich A, Ravery V. European Society of Oncological Urology. Preoperative imaging in renal cell cancer. World J Urol. 2004; 22:307–315.
3. Claudon M, Cosgrove D, Albrecht T, Bolondi L, Bosio M, Calliada F, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008. Ultraschall Med. 2008; 29:28–44.
4. Xu ZF, Xu HX, Xie XY, Liu GJ, Zheng YL, Liang JY, et al. Renal cell carcinoma: real-time contrast-enhanced ultrasound findings. Abdom Imaging. 2010; 35:750–756.
5. Lu Q, Wang W, Huang B, Li C, Li C. Minimal fat renal angiomyolipoma: the initial study with contrast-enhanced ultrasonography. Ultrasound Med Biol. 2012; 38:1896–1901.
6. Nilsson A. Contrast-enhanced ultrasound of the kidneys. Eur Radiol. 2004; 14:Suppl 8. P104–P109.
7. Ascenti G, Gaeta M, Magno C, Mazziotti S, Blandino A, Melloni D, et al. Contrast-enhanced second-harmonic sonography in the detection of pseudocapsule in renal cell carcinoma. AJR Am J Roentgenol. 2004; 182:1525–1530.
8. Zhou X, Yan F, Luo Y, Peng YL, Parajuly SS, Wen XR, et al. Characterization and diagnostic confidence of contrast-enhanced ultrasound for solid renal tumors. Ultrasound Med Biol. 2011; 37:845–853.
9. Zhang J, Lefkowitz RA, Ishill NM, Wang L, Moskowitz CS, Russo P, et al. Solid renal cortical tumors: differentiation with CT. Radiology. 2007; 244:494–504.
10. Russo P. Renal cell carcinoma: presentation, staging, and surgical treatment. Semin Oncol. 2000; 27:160–176.
11. Pavlica P, Derchi L, Martorana G, Brunocilla E, Bertaccini A, Manferrari F, et al. Renal cell carcinoma imaging. Eur Urol Suppl. 2006; 5:580–592.
12. Jinzaki M, Tanimoto A, Narimatsu Y, Ohkuma K, Kurata T, Shinmoto H, et al. Angiomyolipoma: imaging findings in lesions with minimal fat. Radiology. 1997; 205:497–502.
13. Quaia E, Palumbo A, Rossi S, Degobbis F, Cernic S, Tona G, et al. Comparison of visual and quantitative analysis for characterization of insonated liver tumors after microbubble contrast injection. AJR Am J Roentgenol. 2006; 186:1560–1570.
14. Quaia E, Calliada F, Bertolotto M, Rossi S, Garioni L, Rosa L, et al. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology. 2004; 232:420–430.
15. Xu ZF, Xu HX, Xie XY, Liu GJ, Zheng YL, Lu MD. Renal cell carcinoma and renal angiomyolipoma: differential diagnosis with real-time contrast-enhanced ultrasonography. J Ultrasound Med. 2010; 29:709–717.
16. Jinzaki M, Tanimoto A, Mukai M, Ikeda E, Kobayashi S, Yuasa Y, et al. Double-phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis. J Comput Assist Tomogr. 2000; 24:835–842.
17. Pickhardt PJ, Lonergan GJ, Davis CJ Jr, Kashitani N, Wagner BJ. From the archives of the AFIP. Infiltrative renal lesions: radiologic-pathologic correlation. Armed Forces Institute of Pathology. Radiographics. 2000; 20:215–243.
18. Setola SV, Catalano O, Sandomenico F, Siani A. Contrast-enhanced sonography of the kidney. Abdom Imaging. 2007; 32:21–28.